Elicio Therapeutics, Inc. (ELTX) Financials

ELTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 31.3 million 23.4 million
March 31, 2026 22.7 million 24.1 million
Dec. 31, 2025 25.9 million 24.2 million
Sept. 30, 2025 28.3 million 24.5 million

ELTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -8.2 million 935000
March 31, 2026 -11.6 million 868000
Dec. 31, 2025 -6.8 million 772000
Sept. 30, 2025 -11.1 million 698000

ELTX Net Income

No data available :(

ELTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 23.5 million - -
March 31, 2026 14.9 million - 4.9 million
Dec. 31, 2025 18.6 million - 5.1 million
Sept. 30, 2025 20.6 million - 5.3 million

ELTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 19.2 million
March 31, 2026 18.2 million
Dec. 31, 2025 15.3 million
Sept. 30, 2025 16.7 million

ELTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 6.8 million 3.6 million -
March 31, 2026 - 6.7 million 3.8 million -
Dec. 31, 2025 16000 5.1 million 3.8 million -
Sept. 30, 2025 - 5.0 million 3.0 million -

ELTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 289000
Dec. 31, 2025 - 286000
Sept. 30, 2025 - 283000

ELTX

Price: $3.04

52 week price:
2.66
16.00

Earnings Per Share: -2.21 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 81.7 million

Links: